[68Ga]Ga-FAPI-46 PET/MRT Unveils Lymph Node Metastases and Changes Treatment Strategy in Recurrent Advanced High-grade Serous Ovarian Carcinoma Patient
High-grade serous ovarian carcinoma (HGOC) is frequently diagnosed at an advanced stage, leading to high recurrence rates. This case report highlights the utility of [ 68 Ga]Ga-FAPI-46 PET/MRI in detecting previously unidentified lymph node metastases in a 75-year-old woman with recurrent HGOC, which altered the treatment strategy. The imaging revealed increased [ 68 Ga]Ga-FAPI-46 uptake in nonenlarged mediastinal and left perihilar lymph nodes, reclassifying the patient from FIGO IIIb to FIGO stage IV and prompting a change in therapeutic management.
Authors
- Frederik Marmé (ORCID: https://orcid.org/0000-0002-6591-3367)
- Freba Grawe (ORCID: https://orcid.org/0009-0002-8259-7359)
- A Hinterberger (ORCID: https://orcid.org/0000-0001-5043-9909)
- Björn Wängler (ORCID: https://orcid.org/0000-0003-3877-5576)
- Marie Prochiner
Institutions
- Heidelberg University (DE)
- Cancer Institute (WIA) (IN)
- University Hospital Heidelberg (DE)
- University Medical Center (US)
- University Medical Centre Mannheim (DE)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1097/rlu.0000000000005871
- Citations
- 1
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 1.05